Progesterone levels on the hCG day and outcomes in vitro fertilization in women with polycystic ovary syndrome

Journal of Assisted Reproduction and Genetics

Volumn 29, Issue 7, 2012, Pages 603-607

  Peng, Cuiying ^a,b,c   Guo, Zifen ^a   Long, Xingyu ^b,c   Lu, Guangxiu ^b,c  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b Reproductive and Genetic Hospital of Citic Xiangya   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Controlled ovarian hyperstimulation; In vitro fertilization; Polycytstic ovary syndrome; Premature luteinization; Progesterone

Indexed keywords

CHORIONIC GONADOTROPIN; PROGESTERONE; RECOMBINANT FOLLITROPIN; TRIPTORELIN;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; INCIDENCE; LUTEINIZATION; MAJOR CLINICAL STUDY; OOCYTE RETRIEVAL; OUTCOME ASSESSMENT; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; RETROSPECTIVE STUDY;

ADULT; CHORIONIC GONADOTROPIN; FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; LUTEINIZATION; OOCYTES; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; PROGESTERONE; RETROSPECTIVE STUDIES;

EID: 84864960858     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-012-9762-6     Document Type: Article

References (27)

1. Broekmans FJ, Knauff EA, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BC. PCOS according to the Rotterdam consensus criteria. Change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG-INT J Obstet Gy. 2006;113:1210-7.
2. Papanikolaou EG, Kolibianakis EM, Pozzobon C, Tank P, Tournaye H, Bourgain C, Steirteghem A, Devroey P. Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer. Fertil Steril. 2009;91:949-52.
3. Bosch E, Valencia I, Escudero E, Crespo J, Simon C, Remohi J, Pellicer A. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil Steril. 2003;80:1444-9.
4. Edelstein MC, Seltman HJ, Cox BJ, Robinson SM, Shaw RA, Muasher SJ. Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin-releasing hormone agonist suppression are not predictive of pregnancy outcome. Fertil Steril. 1990;54:853-7.
5. Martinez F, Coroleu B, Clua E, Tur R, Buxaderas R, Parera N, Barri PN, Balasch J. Serum progesterone concentrations on the day of HCG administration cannot predict pregnancy in assisted reproduction cycles. Reprod Biomed Online. 2004;8:183-90.
6. Melo MA, Meseguer M, Garrido N, Bosch E, Pellicer A, Remohi J. The significance of premature luteinization in an oocytedonation programme. Hum Reprod. 2006;21:1503-7.
7. Fanchin R, de Ziegler D, Taieb J, Hazout A, Frydman R. Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer. Fertil Steril. 1993;59:1090-4.
8. Legro RS, Ary BA, Paulson RJ, Stanczyk FZ, Sauer MV. Premature luteinization as detected by elevated serum progesterone is associated with a higher pregnancy rate in donor oocyte in-vitro fertilization. Hum Reprod. 1993;8:1506-11.
9. Filicori M, Cognigni GE, Arnone R, Carbone F, Falbo A, Tabarelli C, Ciampaglia W, Casadio P, Spettoli D, Pecorari R. Role of different GnRH agonist regimens in pituitary suppression and the outcome of controlled ovarian hyperstimulation. Hum Reprod. 1996;11(Suppl3):123-32.
10. World Health Organization. WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction. 4th ed. Cambridge: Cambridge University Press; 1999.
11. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group, Fauser BCJM. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41-7.
12. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care. 1999;22:141-6.
13. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States. A prospective study. J Clin Endocrinol Metab. 1998;83:3078-82.
14. Christian RC, Dumesic DA, Behrenbeck T, Oberg AL, Sheedy 2nd PF, Fitzpatrick LA. Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003;88:2562-8.
15. Glueck CJ, Morrison JA, Wang P. Insulin resistance, obesity, hypofibrinolysis, hyperandrogenism, and coronary heart disease risk factors in 25 pre-perimenarchal girls age <14or 014 years, 13 with precocious puberty, 23 with a first-degree relative with polycystic ovary syndrome. J Pediatr Endocrinol Metab. 2008;21:973-84.
16. Legro RS. Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocr Rev. 2003;24:302-12.
17. Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome. a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab. 1999;84:165-9.
18. Ovalle F, Azziz R. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertil Steril. 2002;77:1095-105.
19. Mehrabian F, Khani B, Kelishadi R, Ghanbari E. The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria. Endokrynologia Polska/Polish Journal of Endocrinology. 2011;62:238-42.
20. Elnashar AM. Progesterone rise on the day of HCG administration (premature luteinization) in IVF. An overdue update. J Assist Reprod Genet. 2010;27:149-55.
21. Bukulmez O, Rehman KS, Langley M, Carr BR, Nackley AC, Doody KM. Precycle administration of GnRH antagonist and microdose HCG decreases clinical pregnancy rates without affecting embryo quality and blastulation. Reprod Biomed Online. 2006;13:465-75.
22. Li R, Qiao J, Wang L, Zhen X, Lu Y. Serum progesterone concentration on day of HCG administration and IVF outcome. Reprod Biomed Online. 2008;16:627-31.
23. Yovel I, Yaron Y, Amit A, Peyser MR, David MP, Kogosowski A, Lessing JB. High progesterone levels adversely affect embryo quality and pregnancy rates in in vitro fertilization and oocyte donation programs. Fertil Steril. 1995;64:128-31.
24. Hofmann GE, Bentzien F, Bergh PA, Garrisi GJ, Williams MC, Guzman I, Navot D. Premature luteinization in controlled ovarian hyperstimulation has no adverse effect on oocyte and embryo quality. Fertil Steril. 1993;60:675-9.
25. Givens CR, Schriock ED, Dandekar PV, Martin MC. Elevated serum progesterone levels on the day of human chorionic gonadotropin administration do not predict outcome in assisted reproduction cycles. Fertil Steril. 1994;62:1011-7.
26. Schoolcraft W, Sinton E, Schlenker T, Huynh D, Hamilton F, Meldrum DR. Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate. Fertil Steril. 1991;55:563-6.
27. Ubaldi F, Smitz J, Wisanto A, Joris H, Schiettecatte J, Derde MP, Borkham E, Steirteghem AV, Devroey P. Oocyte and embryo quality as well as pregnancy rate in intracytoplasmic sperm injection are not affected by high follicular phase serum progesterone. Hum Reprod. 1995;10:3091-6.